SCHEMBL463059

SCHEMBL463059

Cc1nc2cc(-c3cccc(Cl)c3)nn2c(-c2ccccc2)c1C(=O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.52
DPP8 Q6V1X1 3/20 0.52
DPP9 Q86TI2 2/20 0.52
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPSR1 Q6W5P4 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 1/20 0.46
ABCB1 P08183 1/20 0.46
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
HTT P42858 2/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
KDM4E B2RXH2 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL461428 0.90 DPP4 (0.48) DPP4DPP8DPP9CYP3A4CYP2C9
SCHEMBL463056 0.84 DPP4 (0.47) DPP4DPP8DPP9CYP3A4CYP2C9
SCHEMBL461396 0.82 DPP4 (0.46) DPP4DPP8DPP9CYP3A4CYP2C9
SCHEMBL463058 0.81 NPSR1 (0.44) DPP4DPP8DPP9NPSR1KMT2A
SCHEMBL12079176 0.81 DPP4 (0.50) DPP4DPP8DPP9CYP3A4CYP2C9
SCHEMBL461152 0.78 DPP4 (0.47) DPP4DPP8DPP9CYP3A4CYP2C9
SCHEMBL461843 0.77 DPP4 (0.46) DPP4DPP8DPP9NPSR1KMT2A
SCHEMBL462684 0.77 MAPT (0.79) DPP4DPP8DPP9CYP3A4CYP2C9
SCHEMBL12079870 0.76 NR1I2 (0.59) DPP4DPP8DPP9CYP3A4CYP2C9
SCHEMBL462612 0.76 NR1I2 (0.59) DPP4DPP8DPP9CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2614064-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Bristol-Myers Squibb Company (US) 2013-07-17 EP disclosed
WO-2012033735-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed